Pluri (PLUR) Debt Ratio (2018 - 2025)
Pluri (PLUR) reported Debt Ratio of 0.91 for Q4 2025, up 17.75% year-over-year from 0.77 in Q4 2024, and up 11.02% quarter-over-quarter from 0.82 in Q3 2025.
Pluri (PLUR) Debt Ratio (2018 - 2025) Analysis & Trends
Pluri (PLUR) has 6 years of Debt Ratio data on file, last reported at 0.91 in Q4 2025.
- Debt Ratio for Q4 2025 came in at 0.91, up 17.75% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.91 (up 17.75% YoY), and the FY2025 annual result was 0.71, up 16.05% from the prior year.
- Debt Ratio climbed to 0.91 in Q4 2025 per PLUR's latest filing, from 0.82 in the prior quarter.
- Over five years, Debt Ratio peaked at 0.91 in Q4 2025 and troughed at 0.25 in Q2 2021.
- A 5-year average of 0.53 and a median of 0.52 in 2023 frame the typical range for Debt Ratio.
- The sharpest annual moves came in 2024 and 2025: Debt Ratio jumped 59.31% in 2024, then rose 0.85% in 2025.
- A 5-year view of Debt Ratio shows it stood at 0.29 in 2021, then soared by 32.65% to 0.38 in 2022, then surged by 55.15% to 0.59 in 2023, then surged by 31.35% to 0.77 in 2024, then increased by 17.75% to 0.91 in 2025.
- Business Quant data shows PLUR's Debt Ratio at 0.91 in Q4 2025, 0.82 in Q3 2025, and 0.71 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 0.18 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 | 0.91 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.91 |
| Sep 30, 2025 | 0.82 |
| Jun 30, 2025 | 0.71 |
| Mar 31, 2025 | 0.67 |
| Dec 31, 2024 | 0.77 |
| Sep 30, 2024 | 0.72 |
| Jun 30, 2024 | 0.61 |
| Mar 31, 2024 | 0.66 |
| Dec 31, 2023 | 0.59 |
| Sep 30, 2023 | 0.52 |
| Jun 30, 2023 | 0.46 |
| Mar 31, 2023 | 0.42 |
| Dec 31, 2022 | 0.38 |
| Sep 30, 2022 | 0.35 |
| Jun 30, 2022 | 0.32 |
| Mar 31, 2022 | 0.29 |
| Dec 31, 2021 | 0.29 |
| Sep 30, 2021 | 0.28 |
| Jun 30, 2021 | 0.25 |
| Jun 30, 2018 | 0.01 |